COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020
Cited by 612 works. doi:10.1016/s1470-2045(20)30314-4
Authors
- Marina Chiara Garassino
- Jennifer G. Whisenant
- Li‐Ching Huang
- Annalisa Trama
- Valter Torri
- Francesco Agustoni
- Javier Baena
- Giuseppe Luigi Banna
- Rossana Berardi
- Anna Bettini
- Emilio Bria
- Matteo Brighenti
- Jacques L. Cadranel
- Alessandro De Toma
- Claudio Chini
- Alessio Cortellini
- Enriqueta Felip
- Giovanna Finocchiaro
- Pilar Garrido
- Carlo Genova
References
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- Clinical Characteristics of Coronavirus Disease 2019 in China
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- Cancer statistics, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period